Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Tatsuharu Ohno"'
Autor:
Masaaki Tsuji, Tatsuki Uchiyama, Chisaki Mizumoto, Tomoharu Takeoka, Kenjiro Tomo, Tatsuharu Ohno
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Myeloid blast crisis of chronic myeloid leukemia (CML-MBC) is rarely seen at presentation and has a poor prognosis. There is no standard therapy for CML-MBC. It is often difficult to distinguish CML-MBC from acute myeloid leukemia expressing the Phil
Externí odkaz:
https://doaj.org/article/23ebbc1230a849bc923bc6f422487287
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2017 (2017)
Case Reports in Hematology, Vol 2017 (2017)
Myeloid blast crisis of chronic myeloid leukemia (CML-MBC) is rarely seen at presentation and has a poor prognosis. There is no standard therapy for CML-MBC. It is often difficult to distinguish CML-MBC from acute myeloid leukemia expressing the Phil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4e9cc6adcb823bd720a5ade3d356f0
https://doi.org/10.1155/2017/3209305
https://doi.org/10.1155/2017/3209305
Autor:
Yusuke, Narita, Tatsuki, Uchiyama, Chisaki, Mizumoto, Tomoharu, Takeoka, Kenjiro, Tomo, Masaaki, Tsuji, Tatsuharu, Ohno
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 59(11)
A 44-year-old woman in the first remission phase of mixed-phenotype acute leukemia (T-lymphoid and myeloid lineages) suddenly exhibited thrombocytopenia (1.1×10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f2a8d60caeda43bac1dd0bfd0cfac28
https://pubmed.ncbi.nlm.nih.gov/30531136
https://pubmed.ncbi.nlm.nih.gov/30531136
Autor:
Chisaki Mizumoto, Naoki Sakai, Tatsuharu Ohno, Yuko Kazumi, Masaaki Tsuji, Yoshihiko Hoshino, Kenjiro Tomo, Daisuke Naito, Tomoharu Takeoka
Publikováno v:
Nihon Naika Gakkai Zasshi. 105:717-723
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa5a29dc0cbc0e29f12962b0bd28e8a8
https://doi.org/10.2169/naika.105.717
https://doi.org/10.2169/naika.105.717
Autor:
Hideki Asaoku, Takayuki Saitoh, Mitsuhiro Itagaki, Yoshiaki Kuroda, Toshio Wakayama, Naoko Harada, Tetsuhiro Kasamatsu, Chihiro Shimazaki, Hiroyuki Hata, Takahiro Kobayashi, Shuji Ozaki, Takaaki Miyake, Chiaki Nakaseko, Masahiro Abe, Hiroshi Handa, Tohru Murayama, Takaaki Cho, Tadao Ishida, Tatsuharu Ohno, Eiich Nagura, Naoki Takezako, Kazutaka Sunami, Junya Kuroda, Kazuyuki Shimizu, Nobumasa Inoue, Shotaro Hagiwara, Akiko Negoro, Jun Konishi
Publikováno v:
Hematological oncology. 36(5)
The international staging system (ISS) is the most commonly used risk-stratification system for patients with multiple myeloma (MM) and is determined by serum albumin and β2-microglobulin levels. In the two determinants, β2-microglobulin levels are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80bc29f5ff0bdc2f4b118ca218f691c6
https://pubmed.ncbi.nlm.nih.gov/30176173
https://pubmed.ncbi.nlm.nih.gov/30176173
Autor:
T Uchiyama, Chisaki Mizumoto, Tomoko Okuno, Kenjiro Tomo, Tomoharu Takeoka, Tatsuharu Ohno, Koji Takaori, Yayoi Shimazu, Masaaki Tsuji, Naoki Sakai
Publikováno v:
Internal Medicine
IgG4-related disease (IgG4RD) is a multi-organ disorder characterized by an elevated serum IgG4 level and IgG4-positive plasma cell infiltration of the affected organs, accompanied by tissue fibrosis and sclerosis. Although it can affect any organ, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621453a5f3e7577c717846607642aacc
https://pubmed.ncbi.nlm.nih.gov/29491289
https://pubmed.ncbi.nlm.nih.gov/29491289
Publikováno v:
Clinical Hematology and Research. 1
Post Transplant Lymphoproliferative Disorders (PTLDs) are serious complication after solid organ or Hematopoietic Stem Cell Transplantation (HSCT). Hodgkin's Lymphoma (HL)-like PTLD is grouped with HL type PTLD in the World Health Organization. HL ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6062a099b07e3b3fba5693e5a074029
https://doi.org/10.36959/831/377
https://doi.org/10.36959/831/377
Autor:
Daisuke, Naito, Chisaki, Mizumoto, Tomoharu, Takeoka, Masaaki, Tsuji, Kenjiro, Tomo, Yuko, Kazumi, Yoshihiko, Hoshino, Naoki, Sakai, Tatsuharu, Ohno
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 105(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d44662fe2e1647b0cfca5364b54f1329
https://pubmed.ncbi.nlm.nih.gov/27491265
https://pubmed.ncbi.nlm.nih.gov/27491265
Autor:
Naohiro Sekiguchi, Hideto Tamura, Hirokazu Murakami, Kazuhito Suzuki, Shigeki Ito, Yoriko Harazaki, Atsushi Isoda, Hiroki Sugimori, Takeshi Odajima, Shin-ichi Fuchida, Ayumi Fujimoto, Mineo Kurokawa, Akio Saito, Yutaka Tsukune, Hideyuki Nakazawa, Reiko Watanabe, Hiroyuki Takamatsu, Nobuhiko Nakamura, Kanji Miyazaki, Michiaki Koike, Shuji Ozaki, Tatsuharu Ohno, Shotaro Hagiwara, Hideo Yagi, Yuichi Nakamura, Kazutaka Sunami, Takae Kohara, Akihiko Yokohama, Mitsuhiro Itagaki, Toshio Wakayama, Go Yamamoto
Publikováno v:
Blood. 132:5320-5320
Background: We recently reported that the International Prognostic Scoring System for Waldenström macroglobulinemia (ISSWM), which is widely used to predict the prognosis of WM patients, might not be applicable to Japanese patients, and evidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5904886dc7c28a9e42bbfb8b6805514
https://doi.org/10.1182/blood-2018-99-111649
https://doi.org/10.1182/blood-2018-99-111649
Autor:
Junya Kanda, Hiromi Kitao, Masaaki Tsuji, Kazunori Imada, Kosuke Asagoe, Kouhei Yamashita, Toshinori Moriguchi, Ihhwa Kim, Mitsumasa Watanabe, Kenji Ueshima, Masaharu Nohgawa, Akifumi Takaori-Kondo, Yasunori Ueda, Toshiyuki Toshiyuki, Shinji Yasuno, Takayuki Ishikawa, Mitsuru Itoh, Masayuki Kobayashi, Yoshihiro Kuwabara, Takeo Nakayama, Tatsuharu Ohno, Takeshi Maeda, Nobuyoshi Arima, Shinjiro Tominari, Hitoshi Ohno, Hirokazu Hirata, Naoyuki Anzai, Akihito Yonezawa, Kiyomi Kawagishi
Publikováno v:
Blood. 132:3305-3305
Background: Three drug combinations are the standard treatment for newly diagnosed multiple myeloma (NDMM). However, induction, consolidation, and maintenance therapy have not been standardized in Japan. Therefore, in this single arm Phase II study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9982255de2a053cd2b5d951df2108ce5
https://doi.org/10.1182/blood-2018-99-113816
https://doi.org/10.1182/blood-2018-99-113816